Mi Deng

12PUBLICATIONS
45CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 13, 2026
Generative AI-driven de novo design of high-affinity, epitope-specific antibodies targeting the CD93-IGFBP7 axis for cancer immunotherapy.

|Jun 24, 2026
Inhibition of Pax6 sumoylation suppresses the tumorigenicity of pancreatic cancer cells.

|May 18, 2026
Systematic functional screening of immunoreceptor tyrosine-based inhibitory motif domains identifies potent inhibitory modules for chimeric antigen receptor-T.

|Apr 21, 2026
Chidamide synergizes with cisplatin-etoposide to trigger pyroptosis and anti-tumor immunity in diffuse large B-cell lymphoma.

|Mar 03, 2026
In situ-generated vaccine-like pyroptosome for personalized cancer immunotherapy.

Binlong Chen, Fangjie Wan, Heming Xia

|Mar 27, 2025
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development.

Yubo He, Chengcheng Zhang, Lingxiao Tan

Pageof 2

Frequent Collaborators

4 joint publications

Ningyan Zhang

3 joint publications

Zhiqiang An

2 joint publications

Cheryl Lewis

2 joint publications

Yasuaki Anami